Lsi Europe 2521 Jun, 2024Business
InHeart, a pioneering medical device company, recently secured $11 million in fresh capital to accelerate the development and deployment of its innovative therapeutic and predictive cardiac solutions. The financing, led by Vesalius Biocapital IV and co-led by Elaia Partners, will enable InHeart to enhance its digital twin cardiac modeling technology and expand its commercial presence.
Km88 Plataforma
Luck8
Mv66courses
Oke88
Jun88
Buzz Cars
Go8
Luck8
Dandekeps
Hines Cowan